137 related articles for article (PubMed ID: 36075132)
41. Collagenase-Encapsulated pH-Responsive Nanoscale Coordination Polymers for Tumor Microenvironment Modulation and Enhanced Photodynamic Nanomedicine.
Liu J; Tian L; Zhang R; Dong Z; Wang H; Liu Z
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43493-43502. PubMed ID: 30468076
[TBL] [Abstract][Full Text] [Related]
42. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy.
Zhong W; Wong KH; Xu F; Zhao N; Chen M
Acta Biomater; 2022 Jun; 145():135-145. PubMed ID: 35381398
[TBL] [Abstract][Full Text] [Related]
43. Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.
Prasad P; Gordijo CR; Abbasi AZ; Maeda A; Ip A; Rauth AM; DaCosta RS; Wu XY
ACS Nano; 2014 Apr; 8(4):3202-12. PubMed ID: 24702320
[TBL] [Abstract][Full Text] [Related]
44. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
45. Use of perfluorochemical emulsions in cancer therapy.
Teicher BA
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527
[TBL] [Abstract][Full Text] [Related]
46. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
47. Robust O
Wu CY; Hsu YH; Chen Y; Yang LC; Tseng SC; Chen WR; Huang CC; Wan D
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38090-38104. PubMed ID: 34342219
[TBL] [Abstract][Full Text] [Related]
48. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
Li W; Sun X
Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
[TBL] [Abstract][Full Text] [Related]
49. PEGylated Prussian blue nanoparticles for modulating polyethyleneimine cytotoxicity and attenuating tumor hypoxia for dual-enhanced photodynamic therapy.
Wang H; Qu R; Chen Q; Zhang T; Chen X; Wu B; Chen T
J Mater Chem B; 2022 Jul; 10(28):5410-5421. PubMed ID: 35775500
[TBL] [Abstract][Full Text] [Related]
50. Perfluorohexane-Loaded Polymeric Nanovesicles with Oxygen Supply for Enhanced Sonodynamic Therapy.
Zeng Q; Qiao L; Cheng L; Li C; Cao Z; Chen Z; Wang Y; Liu J
ACS Biomater Sci Eng; 2020 May; 6(5):2956-2969. PubMed ID: 33463260
[TBL] [Abstract][Full Text] [Related]
51. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy.
Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L
Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825
[TBL] [Abstract][Full Text] [Related]
52. CaCO
Li H; Zhang X; Lin X; Zhuang S; Wu Y; Liu Z; Rong J; Zhao J
J Mater Chem B; 2020 Feb; 8(6):1223-1234. PubMed ID: 31950968
[TBL] [Abstract][Full Text] [Related]
53. Colorectal Tumor Microenvironment-Activated Bio-Decomposable and Metabolizable Cu
Chang M; Hou Z; Jin D; Zhou J; Wang M; Wang M; Shu M; Ding B; Li C; Lin J
Adv Mater; 2020 Oct; 32(43):e2004647. PubMed ID: 32945002
[TBL] [Abstract][Full Text] [Related]
54. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.
Teicher BA
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1109-20. PubMed ID: 7849913
[TBL] [Abstract][Full Text] [Related]
55. Calcium Bisphosphonate Nanoparticles with Chelator-Free Radiolabeling to Deplete Tumor-Associated Macrophages for Enhanced Cancer Radioisotope Therapy.
Tian L; Yi X; Dong Z; Xu J; Liang C; Chao Y; Wang Y; Yang K; Liu Z
ACS Nano; 2018 Nov; 12(11):11541-11551. PubMed ID: 30359515
[TBL] [Abstract][Full Text] [Related]
56. CaCO
Zhu Y; Yang Z; Dong Z; Gong Y; Hao Y; Tian L; Yang X; Liu Z; Feng L
Nanomicro Lett; 2020 Nov; 13(1):29. PubMed ID: 34138248
[TBL] [Abstract][Full Text] [Related]
57. Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC.
Sun Y; Yang J; Li Y; Luo J; Sun J; Li D; Wang Y; Wang K; Yang L; Wu L; Sun X
Mol Cancer; 2022 Dec; 21(1):212. PubMed ID: 36457016
[TBL] [Abstract][Full Text] [Related]
58. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
59. Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy.
Zhang YX; Zhao YY; Shen J; Sun X; Liu Y; Liu H; Wang Y; Wang J
Nano Lett; 2019 May; 19(5):2774-2783. PubMed ID: 30943039
[TBL] [Abstract][Full Text] [Related]
60. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
